Clinical Trials – the newest treatments available
Clinical trials are scientific studies that involve people to evaluate a new potential drug or therapy that’s already been studied in the laboratory. The trials are conducted to examine what dose is considered safe, how well it works and whether it’s more effective than current standard treatments. All drugs and treatments currently used were once studied in clinical trials.
With more than a century of groundbreaking research, Roswell Park is uniquely poised to convert the latest scientific discoveries into real-word innovations and therapies to reduce the burden of cancer. Participating in a clinical trial is the only way to access the very latest drugs and treatments, often times years before a drug would become available to other providers.
As a Comprehensive Cancer Center designated by the National Cancer Institute (NCI), Roswell Park’s researchers and clinicians are part of the worldwide effort to develop new and better cancer therapies. Roswell Park was selected to be part of an Ovarian Cancer Specialized Program of Research Excellence (SPORE), funded by the NCI, which focuses research on immune-based approaches in ovarian cancer. With this SPORE and other research at Roswell Park, we offer several trials for ovarian cancer, including the following approaches:
- Immunotherapy (including adoptive T-Cell transfer, vaccines, oncolytic viral therapy, checkpoint inhibitors)
To learn about clinical trial options for ovarian cancer at Roswell Park, click here.